PPI network analysis results suggest that the core targets of ECXB formula for the treatment of COPD mainly include MAPK8, ESR1, TP53, MAPK3, JUN, RELA, MAPK1, and AKT1. This evidence concerns the gene AKT1 and chronic obstructive pulmonary disease.